-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
CATALYST PHARMACEUTICALS, INC. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2018 to Q3 2025.
- CATALYST PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 127M shares, a 1.34% increase year-over-year.
- CATALYST PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 125M shares, a 9.84% increase from 2023.
- CATALYST PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 114M shares, a 2.14% increase from 2022.
- CATALYST PHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 111M shares, a 3.32% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)